The Executive Director, Market Access, reporting to the Vice President of Commercial Development, will be responsible for ensuring appropriate coverage for Rivoceranib-Camrelizumab and Lirafugratinib across Payers (Private and Public), Pathways and GPOs in the US.
This position will be instrumental in helping Elevar design and build out the National Account team/planning and execution, while working with leadership to ensure success in this dynamic landscape. As Executive Director, Market Access, this individual would be expected to liaise across functions to ensure overall commercial alignment to company goals and objectives while appropriately managing the day-to-day operations of their accounts. This is a remote-based position.
Responsibilities:
The anticipated annual base salary range for this role is $200,000 to $285,000. Final compensation depends on multiple factors including but not limited to, relevant experience, skillset, depth and breadth of knowledge, internal equity, and external market factors. Elevar Therapeutics is a rapidly growing biotech company that offers competitive wages and benefits package including medical, dental, vision, time off, a retirement plan, and other voluntary benefits for employees.
#LI-REMOTE

Fiserv

Stride, Inc.

Wannado

Danaher Corporation

Zillow

Elevar Therapeutics

Elevar Therapeutics

Elevar Therapeutics